১৫ জুন মামলার পরবর্তী শুনানি।
Source link
Next Post
US approves first new Alzheimer's drug in 20 years
Mon Jun 7 , 2021
In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking problems than a dummy drug. Source link

You May Like
-
6 years ago
ऑफिस में काम की शुरुआत 20 बड़ी खबरों के साथ
-
6 years ago
ऑफिस में काम की शुरुआत 20 बड़ी खबरों के साथ